(1) Treat leucopenia after radiochemotherapy for cancer patient.

(2) The common adverse reactions were leucopenia, anemia, neuro-sensory toxicity and gastrointestinal response.

(3) Methods: The clinical manifestation of 11 cases with leucopenia ATD were analyzed retrospectively.

(4) Objective To investigate the treatment of grade IV leucopenia after chemotherapy in patients with carcinoma.

(5) The patient developed diarrhea, fever and leucopenia during anti - rheumatoid drug treatments.

(6) Methods The clinical manifestation of 11 cases with leucopenia caused by ATD were analyzed retrospectively.

(7) The most common adverse effects were leucopenia, hand-foot syndrome(Sentence dictionary), diarrhea and skin pigmentation. There was no treatment-related death.

(8) Objective To study the leukogenic effects on leucopenia model induced by X-ray and chemotherapy.

(9) Conclusion The changing regularity of the hypocellular leucopenia after chemotherapy could be significant reference for clinical treatment.

(10) Most common adverse events were leucopenia (60%), anemia (62%), nausea and vomiting (30%), alopecia (100%). There were no chemotherapy-related deaths.

(11) It is used tablet and injection etc, and curing cancer, leucopenia disease, chronic tracheitis of bronchus asthma and panting mould, bacillary dysentery and enteritis etc.

(12) Results:The effects of anti - rejection Among ALG- P and ATG are similar, but the incidence of leucopenia descend and pulmonary infection were higher in those taking ATG.

(13) Objective To investigate the characteristic of attendance in patients with leucopenia caused by antithyroid drug(ATD) in order to guide the clinical work.

(14) Objective To observe the clinical effect of Bazhen decoction on the treatment of leucopenia after chemotherapy.

(15) This article reports the effects of pure Astragalus preparation(PAP) in treating 115 cases of leucopenia.

(16) Conclusion Benzene-exposure employee with qi-deficiency, blood-deficiency and yin-deficiency or the disease location in spleen and kidney is liable to cause leucopenia.

(17) METHODS:Using pharmacoeconomic cost-effectiveness analysis, GM-CSF was compared with G-CSF in treatment of leucopenia in chemotherapy of cancer.

(18) Concurrent with the rise in body temperature is the development of leucopenia.

(19) Allele A5 and A5.1 of exon 5 in MICA gene were associated with psychotropics-induced leucopenia.

(20) AIM:To compare the therapeutic effect, adverse reactions and the costs between GM-CSF and G-CSF in treating leucopenia in chemotherapy of cancer.